首页> 外国专利> PRODUCTION OF 1ALPHA,25-DIHYDROXYVITAMINS D4 AND D7

PRODUCTION OF 1ALPHA,25-DIHYDROXYVITAMINS D4 AND D7

机译:生产1α-,25-羟基维生素D4和D7

摘要

PURPOSE: To obtain the subject compounds having differentiation-inducing activity and osteogenetic activity by converting a 22C alcohol derivative obtained from stigmasterol into a 5,7-diene modification via several processes followed by subjecting the 5,7-diene modification to ultraviolet-light irradiation and thermal isomerization successively. ;CONSTITUTION: A 22C alcohol derivative of formula I (Ph denotes phenyl) obtained from stigmasterol is tosylated and then treated with NaI to convert into a 22-iodine modification, which is then condensed with a sulfone derivative of formula II (R1 is methyl or H; R2 is H or methyl; Et denotes ethyl) to produce a 23-phenylsulfone derivative of formula III. This derivative is then subjected to reductive desulfurization followed by selectively α-epoxidize the double bond of the derivative of formula III, and the protecting group for the hydroxyl group of this compound is eliminated to convert into a diol compound followed by reducing the epoxy group of the diol compound to change into a triol compound, which is, in turn, subjected to ultraviolet-light irradiation and thermal isomerization successively, thus obtaining the objective 1α,25- dinydroxyvitamins D4 and D7 of formula IV.;COPYRIGHT: (C)1995,JPO
机译:目的:通过几种方法将得自豆甾醇的22C醇衍生物转化为5,7-二烯修饰,然后将5,7-二烯修饰进行紫外线照射,从而获得具有分化诱导活性和成骨活性的主题化合物。和热异构化相继。 ;组成:将得自豆甾醇的式I 22C醇衍生物(Ph表示苯基)甲苯磺酸化,然后用NaI处理,转化为22-碘修饰,然后与式II砜衍生物缩合(R 1 是甲基或H; R 2 是H或甲基; Et表示乙基),生成式III的23-苯基砜衍生物。然后对该衍生物进行还原脱硫,然后选择性地α-环氧化式Ⅲ衍生物的双键,并消除该化合物羟基的保护基,转化为二醇化合物,然后还原环氧基。二醇化合物转变为三醇化合物,然后依次进行紫外线照射和热异构化,从而获得目标1α,25-二乙氧基维生素D 4 和D 式IV的第7 页;版权:(C)1995,日本特许厅

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号